Paul J Sekhri bought $84k of VTVT
Pres, CEO and Exec Chairperson at vTv Therapeutics Inc.. 5,000 shares at an average of $16.76, traded Nov 15, 2024, filed Nov 19, 2024.
Score components
- +25RoleCEO
- +9Trade size$84k at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
- -1510b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -11.6%, 3m +18.6%, 6m +26.3%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001641489-24-000078, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 15, 2024 | POpen-market purchase Class A Common Stock10b5-1 | +1,378 | $16.35 | $23k | 1,378 | Nov 19, 2024 |
| Nov 15, 2024 | POpen-market purchase Class A Common Stock10b5-1 | +1,778 | $16.88 | $30k | 3,156 | Nov 19, 2024 |
| Nov 18, 2024 | POpen-market purchase Class A Common Stock10b5-1 | +1,844 | $16.96 | $31k | 5,000 | Nov 19, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.